Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
Cancer care across the healthcare continuum has been revolutionized by advances in the understanding and application of genomics. The paradigm shift to biomarker-driven treatment decisions is a large step toward achieving precision oncology, which is the use of tumor-specific information, like genomic information, to inform cancer care.
A variant of uncertain significance (VUS) detected through germline biomarker testing can be challenging to explain to patients. When a variant is classified as a VUS, there is not enough information available to determine whether it is pathogenic or benign. A VUS is not actionable. Use this FAQ sheet to learn about a VUS, so the next time your patient has questions about this finding, you are prepared to provide guidance.
Get a comprehensive overview of cancer treatment options and oncologic emergencies. Learn nursing interventions to successfully identify and manage disease and treatment-related symptoms. The Treatment and Symptom Management online course offers foundational knowledge for the safe and effective care of the oncology patient. This course is designed for oncology nurses with some experience in oncology.
Apply the biomarker testing nursing process to your practice to guide the delivery of genomic care to all patients with cancer.
New targeted therapies for Metastatic Colorectal Cancer have increased the need for awareness, education and training for nurses to prepare them to confidently manage and educate patients. This interactive activity will include a combination of learning strategies to build competencies and confidence in the area of side effect management.
New targeted therapies for Metastatic Colorectal Cancer have increased the need for awareness, education and training for nurses to prepare them to confidently manage and educate patients. This interactive activity will include a combination of learning strategies to build competencies in the area of diagnostic testing and treatment options.
Dr. Friend reviews biomarker basics, which sets an important foundation to understand how biomarkers and biomarker testing informs treatment decisions and oncology nursing care. She reviews the different types of biomarkers and the classification of variants so that you can use the right terms in practice when speaking to the patient or the healthcare team. She then applies what she taught through a multitude of case examples.
Dr. Mahon provides an overview of germline testing and implications for nursing practice. She introduces the assessment findings that would lead to a referral to a genetics healthcare professional and the need of germline testing. She then reviews the possible outcomes of germline testing and what that interpretation means for the oncology nurse providing care to the patient.
Dr. Kelly provides an overview of liquid biopsy and its applications to oncology nursing care. After she reviews the evolving technology and clinical indications, she will talk through an analysis of advantages and challenges of the utilization of liquid biopsy. She will round out her talk by discussing nursing implications and the future of liquid biopsy.